Emergency Medicine PHARMacotherapy research NETwork 🚨 Pushing the EM PharmD profession forward through high quality, collaborative research 📄

Joined February 2021
5 Photos and videos
📢Check out our new publication on forming & maintaining a research network: Emergency Medicine PHARMacotherapy research NETwork (EMPHARM-NET), established to unify investigators, foster mentorship, & advance high-quality EM research authors.elsevier.com/a/1mlSz…

1
1
3
304
📣 Calling all EM clinicians: please take our IRB-approved anonymous survey examining awareness & experience with anti-amyloid therapies Survey link: redcap.link/anti-amyloid_the… We aim to reach a broad EM audience to characterize awareness of AATs & compile innovative strategies

2
3
444
EMPHARM-NET retweeted
@bfaine1 & I penned an editorial called Pharmacists on the Front Lines: Advances in Emergency Medicine Pharmacy Practice on the history and advancement of EM pharmacy culminating in this EM themed issue🚨 academic.oup.com/ajhp/articl…
1
3
8
727
EMPHARM-NET retweeted
Excited to share the Emergency Medicine themed issue of @ASHPOfficial @AJHPOfficial that I guested edited w/ @bfaine1. 20 ( ‼️ ) papers & >50 EM pharmacists - this is a testament to how talented and diverse our EM pharmacy community is! Read here 👉academic.oup.com/ajhp/issue/…

1
10
32
3,864
EMPHARM-NET retweeted
💡 Need one more reason to love your friendly EM pharmacist? Check out this @EMPHARM_NET SR/MA: ⏰ EMP presence was associated with reduced mean DTN time by 14.6 minutes (95 % CI -18.1, −11.1 min) Time for @American_Stroke @American_Heart to take notice?
Just published in #AJEM! 📄 #PhAST1 is the first systematic review & meta-analysis quantifying the impact of #EMPharmD on stroke #doortoneedle times 🧠🚑 📉 Faster treatment 🤝 More interprofessionalism 🏥 Justification for expanding #EMPharmD services doi.org/10.1016/j.ajem.2025.…
1
17
38
5,194
Check out our new SR/MA on the benefits of an EM pharmacist on thrombolytic DTN time in acute ischemic stroke 🧠
Just published in #AJEM! 📄 #PhAST1 is the first systematic review & meta-analysis quantifying the impact of #EMPharmD on stroke #doortoneedle times 🧠🚑 📉 Faster treatment 🤝 More interprofessionalism 🏥 Justification for expanding #EMPharmD services doi.org/10.1016/j.ajem.2025.…
1
6
567
🔥 New study HBV s/p sexual assault: 🏥 1010 patients, 10 @EMPHARM_NET EDs 💉 62.7 % with no/unknown vaccine history - only 5.8% received HBV vaccine 🧪 HBV serology testing 63.6% 🦠 8 patients received HBIG 🚨 Room for improvement in HBV care Free link: sciencedirect.com/science/ar…

1
6
8
732
🔥 Off the Press: Risk factors for enterococcal UTI in ED patients (n=1836, 5% Enterococcus) 🧪 Combination of positive leukocyte esterase (LE ) and negative nitrite (NI−)  significantly associated w/ Enterococcus UTI (aOR 7.1, 95 % CI 3.73–13.5)  sciencedirect.com/science/ar…

6
12
1,047
EMPHARM-NET retweeted
📣Have you heard of antiamyloid therapies for AD? They cause ADEs called ARIAs that are non-specific, typically require MRI & can mimic stroke ⛔ Concomitant thrombolytics/anticoagulants are contraindicated Learn more in our JAMA IM Clinical Insight👉 jamanetwork.com/journals/jam…
3
25
1,839
EMPHARM-NET retweeted
So excited to announce that @SAEM_AEMP is officially an @SAEMonline Academy! Thanks so everyone who worked so hard to get us to this point & continue to promote our mission of advancing EM pharmacy practice! So grateful to work with all of you! @LRayRx @EmergPharm
9
37
1,448
EMPHARM-NET retweeted
14 May 2025
🎉 Big news from #SAEM25 -- AEMP is officially transitioning to an academy within SAEM!! 🥳 We are so excited for the opportunities this will offer us! 🥂 Thankful for all our members & the group of EM pharmacist leaders who made this possible!! #AEMPlify #AEMP25 @SAEMonline
1
18
32
2,278
Hot off the press: 🔥 New EMPHARM-NET study on desmopressin administration in antiplatelet-related ICH. Link here 👇
🔥New @EMPHARM_NET DONT EXPAND Study: 💊Propensity-matched, 11 EDs: desmopressin (n=35) vs. controls (n=140) 😷Desmo patients had higher baseline ICH volumes 🧠No difference in good or excellent hemostatic efficacy assessed via hematoma volume measures sciencedirect.com/science/ar…
3
6
698
📣Check out our latest publication📣 The 2024 EM Pharmacotherapy literature review is here. Check out the most impactful studies of the last year 👇
🚨 Just published in AJEM from @EMPHARM_NET: CuratED: The 2024 Emergency Medicine Drug Lit Review 🔥 11 RCTs 📜 10 guidelines 🔍 7 meta-analyses 💊 DAPT & stroke, steroids & CAP, TXA & ICH, Andexxa & more Stay EM Pharm sharp👇 🔗 doi.org/10.1016/j.ajem.2025.… #FOAMed #MedED
4
544
🔥Hot off the press: @EMPHARM_NET COPY-ED Study: 💊 Oral cephalosporins (n=647) vs IDSA guideline concordant FQ or TMP-SMX (n=204) for pyelonephritis in patients discharged from the ED 🙅‍♀️No difference in 14 d treatment failure @jlkoehl @bfaine1 sciencedirect.com/science/ar…

1
15
41
3,816
EMPHARM-NET retweeted
🚨Should sugammadex be used to reverse the effects of rocuronium in the ED? 🚨 Check out our new @AnnalsofEM Clinical Controversy to learn why you should use it: sciencedirect.com/science/ar… @MGottliebMD 🥊Opposing side coming soon from @EmergPharm & @AM_EM_PharmD

3
10
52
11,052
EMPHARM-NET retweeted
🥊 Sugammadex should NOT be routinely used to reverse to reverse rocuronium for patients in the ED with @AM_EM_PharmD kwnsfk27.r.eu-west-1.awstrac… Shout out to @MeganARech and @MGottliebMD for their take on the pro side!

🚨Should sugammadex be used to reverse the effects of rocuronium in the ED? 🚨 Check out our new @AnnalsofEM Clinical Controversy to learn why you should use it: sciencedirect.com/science/ar… @MGottliebMD 🥊Opposing side coming soon from @EmergPharm & @AM_EM_PharmD
2
7
42
5,697